MeSH Review:
Life Expectancy
Azzouz,
Le,
Ralph,
Walmsley,
Monani,
Lee,
Wilkes,
Mitrophanous,
Kingsman,
Burghes,
Mazarakis,
Murakami,
Johnson,
Clarke,
Guttman,
Stamler,
Daviglus,
Garside,
Dyer,
Greenland,
Neaton,
Tahvanainen,
Tahvanainen,
Kääriäinen,
Höckerstedt,
Lebo,
Ikuta,
Milunsky,
Milunsky,
Facon,
Mary,
Pégourie,
Attal,
Renaud,
Sadoun,
Voillat,
Dorvaux,
Hulin,
Lepeu,
Harousseau,
Eschard,
Ferrant,
Blanc,
Maloisel,
Orfeuvre,
Rossi,
Azaïs,
Monconduit,
Collet,
Anglaret,
Yakoub-Agha,
Wetterwald,
Eghbali,
Vekemans,
Maisonneuve,
Troncy,
Grosbois,
Doyen,
Thyss,
Jaubert,
Casassus,
Thielemans,
Bataille,
Hateboer,
v Dijk,
Bogdanova,
Coto,
Saggar-Malik,
San Millan,
Torra,
Breuning,
Ravine,
Neufeld,
Tatar,
Kopelman,
Epstein,
Tu,
Yin,
Garofalo,
Nerhood,
Sarasin,
Majno,
Llovet,
Bruix,
Mentha,
Hadengue,
- Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H.J., Strohmeyer, G. N. Engl. J. Med. (1985)
- Migration and granulomatous reaction after periurethral injection of polytef (Teflon). Malizia, A.A., Reiman, H.M., Myers, R.P., Sande, J.R., Barham, S.S., Benson, R.C., Dewanjee, M.K., Utz, W.J. JAMA (1984)
- Diagnosis of hemochromatosis. Powell, L.W., George, D.K., McDonnell, S.M., Kowdley, K.V. Ann. Intern. Med. (1998)
- Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Jeyakumar, M., Butters, T.D., Cortina-Borja, M., Hunnam, V., Proia, R.L., Perry, V.H., Dwek, R.A., Platt, F.M. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Expected gains in life expectancy from various coronary heart disease risk factor modifications. Tsevat, J., Weinstein, M.C., Williams, L.W., Tosteson, A.N., Goldman, L. Circulation (1991)
- Dopamine agonist monotherapy in Parkinson's disease. Clarke, C.E., Guttman, M. Lancet (2002)
- Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction. Boersma, H., van der Vlugt, M.J., Arnold, A.E., Deckers, J.W., Simoons, M.L. Eur. Heart J. (1996)
- Smoking, physical activity, and active life expectancy. Ferrucci, L., Izmirlian, G., Leveille, S., Phillips, C.L., Corti, M.C., Brock, D.B., Guralnik, J.M. Am. J. Epidemiol. (1999)
- Rett syndrome from quintuple and triple deletions within the MECP2 deletion hotspot region. Lebo, R.V., Ikuta, T., Milunsky, J.M., Milunsky, A. Clin. Genet. (2001)
- Making a decision about ERT/HRT. Evidence to consider in initiating and continuing protective therapy. Nerhood, R.C. Postgraduate medicine. (2001)
- Contemporary results of anatomic radical prostatectomy. Catalona, W.J., Ramos, C.G., Carvalhal, G.F. CA: a cancer journal for clinicians. (1999)
- Hormone replacement therapy in the menopause: a pro opinion. Smith, H.O., Kammerer-Doak, D.N., Barbo, D.M., Sarto, G.E. CA: a cancer journal for clinicians. (1996)
- Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. Schrag, D., Kuntz, K.M., Garber, J.E., Weeks, J.C. N. Engl. J. Med. (1997)
- A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. O'Meara, J.J., McNutt, R.A., Evans, A.T., Moore, S.W., Downs, S.M. N. Engl. J. Med. (1994)
- A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Tatar, M., Kopelman, A., Epstein, D., Tu, M.P., Yin, C.M., Garofalo, R.S. Science (2001)
- Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Neufeld, E.J. Blood (2006)
- Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy. Facon, T., Mary, J.Y., Pégourie, B., Attal, M., Renaud, M., Sadoun, A., Voillat, L., Dorvaux, V., Hulin, C., Lepeu, G., Harousseau, J.L., Eschard, J.P., Ferrant, A., Blanc, M., Maloisel, F., Orfeuvre, H., Rossi, J.F., Azaïs, I., Monconduit, M., Collet, P., Anglaret, B., Yakoub-Agha, I., Wetterwald, M., Eghbali, H., Vekemans, M.C., Maisonneuve, H., Troncy, J., Grosbois, B., Doyen, C., Thyss, A., Jaubert, J., Casassus, P., Thielemans, B., Bataille, R. Blood (2006)
- Isoniazid preventive therapy in areas of high isoniazid resistance. Sterling, T.R., Brehm, W.T., Frieden, T.R. Arch. Intern. Med. (1995)
- The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Gage, B.F., Cardinalli, A.B., Owens, D.K. Arch. Intern. Med. (1996)
- Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Col, N.F., Pauker, S.G., Goldberg, R.J., Eckman, M.H., Orr, R.K., Ross, E.M., Wong, J.B. Arch. Intern. Med. (1999)
- Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Suh, T.T., Holmbäck, K., Jensen, N.J., Daugherty, C.C., Small, K., Simon, D.I., Potter, S., Degen, J.L. Genes Dev. (1995)
- The cost-effectiveness of preventing AIDS-related opportunistic infections. Freedberg, K.A., Scharfstein, J.A., Seage, G.R., Losina, E., Weinstein, M.C., Craven, D.E., Paltiel, A.D. JAMA (1998)
- Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Adams, P.C., Gregor, J.C., Kertesz, A.E., Valberg, L.S. Gastroenterology (1995)
- Cysteine 64 of Ref-1 is not essential for redox regulation of AP-1 DNA binding. Ordway, J.M., Eberhart, D., Curran, T. Mol. Cell. Biol. (2003)
- Reduced penetrance of the Huntington's disease mutation. McNeil, S.M., Novelletto, A., Srinidhi, J., Barnes, G., Kornbluth, I., Altherr, M.R., Wasmuth, J.J., Gusella, J.F., MacDonald, M.E., Myers, R.H. Hum. Mol. Genet. (1997)
- Long-term studies on carcinogenicity and promoting effect of phenylbutazone in DONRYU rats. Meakawa, A., Onodera, H., Tanigawa, H., Furuta, K., Kanno, J., Matsuoka, C., Ogiu, T., Hayashi, Y. J. Natl. Cancer Inst. (1987)
- Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. Azzouz, M., Le, T., Ralph, G.S., Walmsley, L., Monani, U.R., Lee, D.C., Wilkes, F., Mitrophanous, K.A., Kingsman, S.M., Burghes, A.H., Mazarakis, N.D. J. Clin. Invest. (2004)
- Human endothelial cell life extension by telomerase expression. Yang, J., Chang, E., Cherry, A.M., Bangs, C.D., Oei, Y., Bodnar, A., Bronstein, A., Chiu, C.P., Herron, G.S. J. Biol. Chem. (1999)
- Population kinetics of precursors of IL 2-producing peripheral T lymphocytes: evidence for short life expectancy, continuous renewal, and post-thymic expansion. Rocha, B.B. J. Immunol. (1987)
- Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer. Shepherd, F.A., Cormier, Y., Burkes, R., Evans, W.K., Goss, G., Klimo, P., Feld, R., Taylor, M. Semin. Oncol. (1997)
- Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. Stamler, J., Daviglus, M.L., Garside, D.B., Dyer, A.R., Greenland, P., Neaton, J.D. JAMA (2000)
- Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis. Jordan, T.J., Lewit, E.M., Montgomery, R.L., Reichman, L.B. JAMA (1991)
- Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. Castellano, A.R., Nettleman, M.D. JAMA (1991)
- Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. Kim, J.J., Wright, T.C., Goldie, S.J. JAMA (2002)
- Effect of L-dopa on course of Parkinson's disease. Curtis, L., Lees, A.J., Stern, G.M., Marmot, M.G. Lancet (1984)
- Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Hateboer, N., v Dijk, M.A., Bogdanova, N., Coto, E., Saggar-Malik, A.K., San Millan, J.L., Torra, R., Breuning, M., Ravine, D. Lancet (1999)
- The OLD-1 positive regulator of longevity and stress resistance is under DAF-16 regulation in Caenorhabditis elegans. Murakami, S., Johnson, T.E. Curr. Biol. (2001)
- Heat stress-induced life span extension in yeast. Shama, S., Lai, C.Y., Antoniazzi, J.M., Jiang, J.C., Jazwinski, S.M. Exp. Cell Res. (1998)
- Polycystic liver and kidney diseases. Tahvanainen, E., Tahvanainen, P., Kääriäinen, H., Höckerstedt, K. Ann. Med. (2005)
- Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults. MacLennan, I.C., Chapman, C., Dunn, J., Kelly, K. Lancet (1992)
- Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Coley, C.M., Barry, M.J., Fleming, C., Fahs, M.C., Mulley, A.G. Ann. Intern. Med. (1997)
- Cost-effectiveness of interferon alfa in chronic myelogenous leukemia. Liberato, N.L., Quaglini, S., Barosi, G. J. Clin. Oncol. (1997)
- Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Sarasin, F.P., Majno, P.E., Llovet, J.M., Bruix, J., Mentha, G., Hadengue, A. Hepatology (2001)
- Evaluation of life expectancy in selection of patients undergoing percutaneous cervical cordotomy or subarachnoid phenol block for pain control of costopleural syndrome. Orlandini, G. Pain (1995)